CN105380253A - Cassia seed-ginkgo leaf compound health food - Google Patents
Cassia seed-ginkgo leaf compound health food Download PDFInfo
- Publication number
- CN105380253A CN105380253A CN201510877158.1A CN201510877158A CN105380253A CN 105380253 A CN105380253 A CN 105380253A CN 201510877158 A CN201510877158 A CN 201510877158A CN 105380253 A CN105380253 A CN 105380253A
- Authority
- CN
- China
- Prior art keywords
- ginkgo leaf
- cassia seed
- health food
- parts
- buckthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 title claims abstract description 20
- 150000001875 compounds Chemical class 0.000 title claims abstract description 14
- 235000013402 health food Nutrition 0.000 title abstract description 8
- 241000522254 Cassia Species 0.000 title 1
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 22
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 22
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 19
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 18
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 17
- 241000222336 Ganoderma Species 0.000 claims abstract description 16
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 4
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract 3
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 3
- 235000013305 food Nutrition 0.000 claims description 6
- 244000201986 Cassia tora Species 0.000 claims description 5
- 235000014552 Cassia tora Nutrition 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 235000001497 healthy food Nutrition 0.000 claims 1
- 229920002472 Starch Polymers 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 239000008107 starch Substances 0.000 abstract description 7
- 235000019698 starch Nutrition 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 238000010298 pulverizing process Methods 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 240000008027 Akebia quinata Species 0.000 abstract 2
- 235000007756 Akebia quinata Nutrition 0.000 abstract 2
- 229920001661 Chitosan Polymers 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 241000218628 Ginkgo Species 0.000 description 18
- 241001065361 Gynostemma Species 0.000 description 15
- 241000229143 Hippophae Species 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 239000002994 raw material Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 8
- 238000002386 leaching Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 5
- 230000002402 anti-lipaemic effect Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000002351 wastewater Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
- 239000004380 Cholic acid Substances 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 229960002471 cholic acid Drugs 0.000 description 2
- 235000019416 cholic acid Nutrition 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 150000002926 oxygen Chemical class 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a cassia seed-ginkgo leaf compound health food, belonging to the field of health food. The cassia seed-ginkgo leaf compound health food is prepared from cassia seeds, fiveleaf gynostemma herb, sea-buckthorn, lucid ganoderma, ginkgo leaves and chitosan through extraction and pulverization of the cassia seeds, fiveleaf gynostemma herb, sea-buckthorn, lucid ganoderma and ginkgo leaves, preparation of a mixture of chitosan and starch, blending, etc. The prepared cassia seed-ginkgo leaf compound health food is safe to take and has substantial adjuvant blood fat-reducing effect and low industrial production cost.
Description
Technical field
The present invention relates to a kind of Cassia tora ginkgo leaf compound health-care food, belong to field of health care food.
Background technology
Investigation display, China >=18 year old lipid disorders in residents illness rate is 18.6%, and patient reaches 1.6 hundred million.The dyslipidemia illness rate of 18-44 years old, 45-59 years old and 60 years old crowd is respectively 17%, 22.9% and 23.4%.During visible high fat of blood becomes, common complaint among the elderly, and the various cardiovascular and cerebrovascular diseases caused thus have become in threat, the main chief culprit of the elderly's life.So the health food that invention has an auxiliary antilipemic is the needs of human health, the Gospel of the person that is Hyperlipidemia.
The present invention is directed to the crowd of Hyperlipidemia, based on tcm health preserving theory, in conjunction with modern medical theory, select cassia seed, gynostemma pentaphylla, sea-buckthorn, glossy ganoderma, ginkgo leaf, shitosan to be raw material prescription, there is the health care of auxiliary antilipemic.Cassia seed in side has adjusting blood lipid and regulates blood pressure effect, the functions such as gynostemma pentaphylla in side, sea-buckthorn, ginkgo leaf have promoting blood circulation, reduce blood viscosity, improve microcirculation, scavenging activated oxygen, reduction lipid peroxide contents.In side, lucidum spore powder can block the absorption of gastro-intestinal tract to cholesterol containing triterpenes, and can suppress the activity of cholesterol synthase, therefore has the effect of serum cholesterol-lowering.Shitosan hinders the absorption of fat in alimentary canal, and is excreted, and in addition, shitosan is easy to combine with cholic acid in enteron aisle, makes cholesterol lose conversion and then absorbed condition, and is excreted.To sum up, cassia seed, gynostemma pentaphylla, sea-buckthorn, glossy ganoderma, ginkgo leaf, shitosan, respectively by different mechanism of action and approach, carry out intervening the object reaching reducing blood lipid from multi-level, Mutiple Targets, the collaborative function playing auxiliary antilipemic.
Summary of the invention
The object of the invention is to provide a kind of Cassia tora ginkgo leaf compound health-care food.The product not only edible safety that this technique is obtained, have significant auxiliary lipid-lowering efficacy, and industrial production cost is low, has good market development application prospect.
For achieving the above object, the present invention adopts following technical scheme:
A kind of Cassia tora ginkgo leaf compound health-care food, raw material comprises by mass fraction: cassia seed 33-35 parts, gynostemma pentaphylla 12-14 parts, sea-buckthorn 9-11 part, glossy ganoderma 9-11 parts, ginkgo leaf 12-14 parts, shitosan 19-21 parts.
Preferably, the raw material of described health food comprises by mass fraction: cassia seed 34 parts, gynostemma pentaphylla 13 parts, sea-buckthorn 10 parts, glossy ganoderma 10 parts, ginkgo leaf 13 parts, shitosan 20 parts.
The preparation method of the health food of described auxiliary antilipemic, comprises the steps:
(1) cassia seed, gynostemma pentaphylla, sea-buckthorn, glossy ganoderma, ginkgo leaf raw material lixiviate powder process
Cassia seed, gynostemma pentaphylla, sea-buckthorn, glossy ganoderma, ginkgo leaf raw material are carried out rinsing pulverization process, and raw materials treated to be immersed in purifying waste water of 10 times of quality 1 hour, and be heated to 100 DEG C with multi-function extractor, lixiviate 3 hours, 100 orders filter to obtain a leaching liquor; In filter residue, add purifying waste water of 8 times of quality again, under same extraction temperature, lixiviate 2 hours, obtains secondary leaching liquor; Twice leaching liquor is merged and carries out reduced pressure concentration, be condensed into thick medicinal extract, relative density 1.25-1.30; Dry extract is become again through vacuum drying; Dry extract, through pulverizing, is crossed 80 mesh sieves and is become extract powder for subsequent use;
(2) shitosan starch compound preparation
The starch of shitosan with its twice quality is mixed, crosses 80 mesh sieves for subsequent use;
(3) allocate
The extract powder prepare step (1) and the shitosan starch compound of step (2) mix and stir, automatically to fill glue Nang machine dress glue Nang.
The invention has the advantages that:
(1) raw materials for production of the present invention have cassia seed, gynostemma pentaphylla, sea-buckthorn, glossy ganoderma, ginkgo leaf, shitosan, are State Food and Drug Administration's approval and accreditation has auxiliary lipid-lowering function.
(2) function factor playing adjusting blood lipid in composition of raw materials of the present invention is plant polyose class, flavonoids, Gynostemma Pentaphylum Makino, saponin(e and alkaloid etc.Its mechanism of action mainly contains the activity 1. improving lipoprotein lipase and LCA, thus promotes lipid catabolism, suppresses its synthesis transhipment and deposition on arterial wall; 2. be combined with cholesterol or its conversion product cholic acid or integrate, thus suppress its absorption in intestines, promote degraded and excretion; 3. promoting blood circulation, reduce blood viscosity, improve microcirculation; 4. scavenging activated oxygen, reduction lipid peroxide contents etc.
(3) production Technology of the present invention reaches advanced international level.This technique convenient operation, can realize industrialization continuous seepage, therefore production cost is low.
Detailed description of the invention
Embodiment 1
The composition of Chinese medicine material and mass fraction: cassia seed 34 parts, gynostemma pentaphylla 13 parts, sea-buckthorn 10 parts, glossy ganoderma 10 parts, ginkgo leaf 13 parts, shitosan 20 parts.
Its preparation method comprises the steps:
(1) cassia seed, gynostemma pentaphylla, sea-buckthorn, glossy ganoderma, ginkgo leaf raw material lixiviate powder process
By pulp furnish, through quality standard check select gynostemma pentaphylla, sea-buckthorn, glossy ganoderma, ginkgo leaf raw material, carry out crushing, rinsing process, raw materials treated to be immersed in the purifying waste water of 10 times of quality 1 hour, 100 DEG C are heated to multi-function extractor, lixiviate 3 hours, 100 orders filter to obtain a leaching liquor; In filter residue, add purifying waste water of 8 times of quality again, under same extraction temperature, lixiviate 2 hours, obtains secondary leaching liquor; Merged by twice leaching liquor and carry out reduced pressure concentration, temperature 65 DEG C-75 DEG C, pressure 0.06-0.08MPa, time 3-4 hour, be condensed into thick medicinal extract, relative density 1.25-1.30; Dry extract is become again, temperature 65 DEG C-75 DEG C, pressure 0.06-0.08MPa, time 3-4 hour through vacuum drying; Dry extract, through pulverizing, is crossed 80 mesh sieves and is become extract powder for subsequent use;
(2) shitosan, the preparation of starch compound
By pulp furnish, through quality standard check select shitosan, mix with the starch of its twice quality, cross 80 mesh sieves for subsequent use;
(3) allocate
In 100,000 grades of purification of air workshops by proportioning, weigh cassia seed prepared by step (1), gynostemma pentaphylla, sea-buckthorn, glossy ganoderma, ginkgo leaf raw material extract powder, stir with the shitosan starch compound of step (2) is mixed;
(5) filled capsules, packaging is measured
In 100,000 grades of purification of air workshops, by encapsulated with automatic capsule filler for above-mentioned compound powder, polishing, bottled, sealing, packaging.
(6) product inspection, warehouse-in
Require that carrying out every inspection to finished product measures according to GMP, the warehouse-in conformed with the regulations.
Embodiment 2
The composition of Chinese medicine material and mass fraction: cassia seed 33 parts, gynostemma pentaphylla 14 parts, sea-buckthorn 9 parts, glossy ganoderma 11 parts, ginkgo leaf 14 parts, shitosan 19 parts.
Preparation method is with embodiment 1.
Embodiment 3
The composition of Chinese medicine material and mass fraction: cassia seed 35 parts, gynostemma pentaphylla 12 parts, sea-buckthorn 11 parts, glossy ganoderma 9 parts, ginkgo leaf 12 parts, shitosan 21 parts.
Preparation method is with embodiment 1.
Embodiment 4
Animal experiment and the display of human feeding trial result: serum total cholesterol, the triglycerides index positive, HDL-C, not significantly lower than control group, judges that given the test agent has auxiliary reduction serum total cholesterol or the effect of auxiliary reduction triglycerides.Illustrate that this product has auxiliary lipid-lowering function.
The foregoing is only preferred embodiment of the present invention, all equalizations done according to the present patent application the scope of the claims change and modify, and all should belong to covering scope of the present invention.
Claims (1)
1. a Cassia tora ginkgo leaf compound health-care food, is characterized in that: described healthy food material comprises by mass fraction: cassia seed 33%-35%, gynostemma pentaphylla 12%-14%, sea-buckthorn 9%-11%, glossy ganoderma 9%-11%, ginkgo leaf 12%-14%, shitosan 19%-21%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510877158.1A CN105380253A (en) | 2015-12-03 | 2015-12-03 | Cassia seed-ginkgo leaf compound health food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510877158.1A CN105380253A (en) | 2015-12-03 | 2015-12-03 | Cassia seed-ginkgo leaf compound health food |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105380253A true CN105380253A (en) | 2016-03-09 |
Family
ID=55413508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510877158.1A Pending CN105380253A (en) | 2015-12-03 | 2015-12-03 | Cassia seed-ginkgo leaf compound health food |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105380253A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107668716A (en) * | 2017-11-01 | 2018-02-09 | 佛山市三水区敏俊食品有限公司 | A kind of health food of functions of relaxing muscles and tendons and promoting |
-
2015
- 2015-12-03 CN CN201510877158.1A patent/CN105380253A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107668716A (en) * | 2017-11-01 | 2018-02-09 | 佛山市三水区敏俊食品有限公司 | A kind of health food of functions of relaxing muscles and tendons and promoting |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105079046B (en) | A kind of antitumor soft capsule of full ganoderma lucidum and preparation method thereof | |
| CN102246920B (en) | Health-care food capable of assisting in reduction of blood fat and preparation method thereof | |
| US8524291B2 (en) | Anti-obesity product and its method of preparation | |
| CN103735739A (en) | Slimming composition and preparation method thereof | |
| KR20110054579A (en) | Herbal medicine composite and pill for ophthalmic fatigue relief and eyesight recovery | |
| CN102634441A (en) | Method for preparing health-care vinegar | |
| CN104983698A (en) | Dendrobium officinale polysaccharide buccal tablet and preparation method thereof | |
| CN102754769A (en) | Natural noodle | |
| CN101601474B (en) | Fiveleaf gynostemma herb and lophatherum gracile SOD anti-cancer heath drink and preparation method thereof | |
| CN102845748B (en) | Composition containing tea polyphenol and cordyceps militaris and preparation method thereof | |
| CN109662186A (en) | A kind of auxiliary reducing blood lipid pressed candy and preparation method thereof | |
| CN105176771B (en) | A kind of alkalescent tea wine and preparation method thereof | |
| CN101780242B (en) | Health or medicine composition and preparation method and application thereof | |
| CN105380253A (en) | Cassia seed-ginkgo leaf compound health food | |
| CN103211215A (en) | Health food with function of relaxing bowels and preparation method thereof | |
| CN103202471B (en) | Health food for reducing blood fat in auxiliary manner and preparation method of health food | |
| CN107854590A (en) | A kind of sweet potato saponin extract and its application | |
| CN100444849C (en) | New use of tribulus terrestris extraction | |
| CN102640825A (en) | Lipid-lowering tea for regulating blood lipid | |
| CN105521178B (en) | A kind of soft capsule with aloe and its preparation method and application | |
| CN102511711A (en) | Healthcare food capsule and preparation method for same | |
| CN108065389A (en) | A kind of double ginseng compound health-care food of Cassia | |
| CN106310034A (en) | Pharmaceutical composition for increasing bone density and preparation method thereof | |
| KR20160127390A (en) | Health functional composition extracted from antler for preventing or treating the osteoporosis | |
| CN109136024A (en) | A kind of blood pressure lowering assembled alcoholic drinks and preparation method thereof containing pueraria lobata |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160309 |